StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3
Publishing Date
2021 - 06 - 21
1
2021 - 04 - 19
1
2021 - 01 - 27
1
Sector
Health technology
3
Tags
Active
10
Agreement
10
America
46
Antibiotics
7
Antibody
9
Application
9
Approval
10
Biotech
25
Cancer
54
Care
11
Collaboration
11
Covid
34
Covid-19
25
Device
11
Diabetes
7
Disease
39
Distribution
11
Drug
109
Drug delivery
12
Earnings
7
Ema
7
Europe
17
Expected
28
Fda
14
Food
22
Genetown
9
Global
159
Growing
34
Growth
192
Health
22
Hiv
11
Immunotherapy
7
Infection
10
Infections
9
Influenza
9
Iot
19
License
10
Liver
15
Market
444
Merge
11
N/a
789
Nutrition
12
People
16
Pharma
10
Pharmaceuticals
12
Positive
12
Reach
24
Report
140
Research
88
Respiratory
16
Results
19
Risk
8
Set
11
System
11
Technology
23
Therapeutics
83
Therapy
24
Treatment
98
Trial
13
Vaccine
56
Entities
Astrazeneca plc
1
Eli lilly and company
1
Glaxosmithkline plc
3
Novartis ag
1
Sanofi
1
Vir biotechnology, inc.
2
Symbols
ABB
7
ABBV
5
ACB
4
ACHV
4
AMCX
5
ARVL
19
AUY
5
BAX
5
BHVN
4
BMO
4
BR
4
CLVR
4
CMCL
4
COHR
4
CTVA
4
CVAC
6
DVN
4
EDUC
4
EMN
4
ENPH
4
EOLS
6
EPC
5
ERIC
5
EVGN
8
EVRI
8
EXPR
7
FNV
5
GE
5
GEVO
4
GOOG
4
GOOGL
4
HBM
5
HCDI
7
HEXO
6
HON
4
HUBS
9
INTC
5
JNJ
15
LITE
4
LLY
8
MDT
10
MMM
9
MS
12
MSFT
4
NEM
5
NOC
4
NOK
4
NVRO
4
NXST
6
OBSV
6
PHG
4
PKX
5
POOL
4
RVNC
5
RY
5
SNY
14
SPGI
5
TMO
5
TRU
6
VIVE
14
Exchanges
Nasdaq
3
Nyse
3
Crawled Date
2021 - 06 - 21
1
2021 - 04 - 19
1
2021 - 01 - 27
1
Crawled Time
12:00
2
18:00
1
Source
www.biospace.com
1
www.globenewswire.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Ev
symbols :
GSK
save search
GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for Sotrovimab
Published:
2021-06-21
(Crawled : 12:00)
- biospace.com/
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-0.23%
|
O:
-0.15%
H:
0.33%
C:
0.0%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-82.77%
|
O:
0.5%
H:
6.27%
C:
5.89%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.41%
|
O:
-0.32%
H:
0.17%
C:
-0.13%
ev
biotech
technology
iot
Outlook on the Digital Respiratory Devices Global Market to 2030 - Focus on Sensors, Smart Inhalers & Nebulizers, Application, Countries and Competitive Landscape
Published:
2021-04-19
(Crawled : 18:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
7.2%
|
O:
0.53%
H:
0.09%
C:
-0.12%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
5.3%
|
O:
0.11%
H:
0.67%
C:
0.5%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
35.1%
|
O:
1.77%
H:
0.33%
C:
-0.02%
sensor
respiratory
ev
device
Lilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19
Published:
2021-01-27
(Crawled : 12:00)
- globenewswire.com
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
1.3%
|
O:
-1.12%
H:
0.1%
C:
-1.6%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
241.44%
|
O:
-0.78%
H:
0.45%
C:
-1.66%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-89.73%
|
O:
-7.13%
H:
96.21%
C:
15.59%
covid
ev
biotech
trial
Gainers vs Losers
67%
33%
Top 10 Gainers
GBR
|
$1.42
31.48%
11.27%
990K
|
Energy Minerals
KUKE
|
$2.88
2.49%
7.64%
360K
|
MPLN
|
$0.6502
-11.74%
4.51%
2.2M
|
Finance
CXM
4
|
$11.34
-0.44%
4.27%
1.7M
|
Information
PVL
4
|
$1.47
-0.68%
4.08%
77K
|
Energy Minerals
RNR
4
|
$224.74
0.85%
3.52%
310K
|
Finance
PZG
|
$0.4431
0.48%
2.91%
150K
|
Non-Energy Minerals
DBRG
|
$17.3
0.06%
1.97%
1.2M
|
Finance and Insurance
RC
|
$8.62
1.77%
0.81%
1M
|
Finance
SIX
|
$23.45
-0.55%
0.68%
650K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.